Harrow Common Stock Total Equity from 2010 to 2024

HROW Stock  USD 38.08  1.94  4.85%   
Harrow Health Common Stock Total Equity yearly trend continues to be fairly stable with very little volatility. Common Stock Total Equity is likely to outpace its year average in 2024. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
2006-06-30
Previous Quarter
30 K
Current Value
30 K
Quarterly Volatility
8.2 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harrow Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harrow Health's main balance sheet or income statement drivers, such as Interest Expense of 22.4 M, Selling General Administrative of 87.2 M or Selling And Marketing Expenses of 37.7 M, as well as many indicators such as Price To Sales Ratio of 2.67, Dividend Yield of 6.0E-4 or PTB Ratio of 4.9. Harrow financial statements analysis is a perfect complement when working with Harrow Health Valuation or Volatility modules.
  
Check out the analysis of Harrow Health Correlation against competitors.
For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.

Latest Harrow Health's Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of Harrow Health over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Harrow Health's Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harrow Health's overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Slightly volatile
   Common Stock Total Equity   
       Timeline  

Harrow Common Stock Total Equity Regression Statistics

Arithmetic Mean19,750
Geometric Mean15,783
Coefficient Of Variation53.77
Mean Deviation8,896
Median21,000
Standard Deviation10,619
Sample Variance112.8M
Range34.6K
R-Value0.95
Mean Square Error12.7M
R-Squared0.90
Slope2,247
Total Sum of Squares1.6B

Harrow Common Stock Total Equity History

202436.2 K
202334.5 K
202230 K
202127 K
201926 K
201824 K
201721 K

About Harrow Health Financial Statements

Harrow Health investors use historical fundamental indicators, such as Harrow Health's Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harrow Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Total Equity34.5 K36.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harrow Stock Analysis

When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.